Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa (Q46214180)

20 December 2017

title

Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa (English)

1 reference

20 December 2017

travel-associated infection

main subject

0 references

Schistosoma haematobium

0 references

1 reference

Iran Mendonça da Silva

1

1 reference

20 December 2017

Roberto Thiengo

2

1 reference

20 December 2017

Maria José Conceição

3

1 reference

20 December 2017

Luis Rey

4

1 reference

20 December 2017

Henrique Leonel Lenzi

5

1 reference

20 December 2017

Edson Pereira Filho

6

1 reference

20 December 2017

Paulo César Ribeiro

7

1 reference

20 December 2017

publication date

1 July 2005

1 reference

20 December 2017

Memórias do Instituto Oswaldo Cruz

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 December 2017

volume

100

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

445-449

1 reference

20 December 2017

Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Increase of intestinal schistosomiasis after praziquantel treatment in a Schistosoma haematobium and Schistosoma mansoni mixed focus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Persistence of Schistosoma haematobium infection despite multiple courses of therapy with praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Drugs five years later: praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Detection of praziquantel resistance in schistosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Long-term efficacy of single-dose oral treatment in schistosomiasis haematobium

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

The potential of artemether for the control of schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

Resolution and resurgence of schistosoma haematobium-induced pathology after community-based chemotherapy in ghana, as detected by ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762005000400018

10.1590/S0074-02762005000400018

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

16113896

1 reference

20 December 2017